On behalf of University of Düsseldorf, PROvendis offers this opportunity for licensing or co-development.
A PCT application has been filed; WO2014177464 A2.
Wichmann et al.: Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity, Blood 2010, 116(4), 603-613.
Metz et al.: From Determinants of RUNX1/ETO Tetramerization to Small-Molecule Protein-Protein Interaction Inhibitors Targeting Acute Myeloid Leukemia, J. Chem. Inf. Model. 2013, 53(9), 2197-202.
Schanda et al.: Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of NHR2 tetramerization, manuscript available upon request.